17-43104083-AAAGAAGAAG-AAAGAAG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_007294.4(BRCA1):​c.441+36_441+38delCTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00191 in 1,115,902 control chromosomes in the GnomAD database, including 17 homozygotes. Variant has been reported in ClinVar as Benign (★★★). The gene BRCA1 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 0)
Exomes 𝑓: 0.0019 ( 16 hom. )

Consequence

BRCA1
NM_007294.4 intron

Scores

Not classified

Clinical Significance

Benign reviewed by expert panel B:9

Conservation

PhyloP100: 0.583

Publications

6 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • BRCA1-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 17-43104083-AAAG-A is Benign according to our data. Variant chr17-43104083-AAAG-A is described in ClinVar as Benign. ClinVar VariationId is 225704.Status of the report is reviewed_by_expert_panel, 3 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00177 (128/72166) while in subpopulation SAS AF = 0.0136 (18/1320). AF 95% confidence interval is 0.00881. There are 1 homozygotes in GnomAd4. There are 60 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 16 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.441+36_441+38delCTT
intron
N/ANP_009225.1P38398-1
BRCA1
NM_001407581.1
c.441+36_441+38delCTT
intron
N/ANP_001394510.1A0A2R8Y7V5
BRCA1
NM_001407582.1
c.441+36_441+38delCTT
intron
N/ANP_001394511.1A0A2R8Y7V5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.441+36_441+38delCTT
intron
N/AENSP00000350283.3P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.441+36_441+38delCTT
intron
N/AENSP00000418960.2P38398-7
BRCA1
ENST00000470026.6
TSL:1
c.441+36_441+38delCTT
intron
N/AENSP00000419274.2P38398-1

Frequencies

GnomAD3 genomes
AF:
0.00178
AC:
128
AN:
72106
Hom.:
1
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00204
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00174
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000966
Gnomad SAS
AF:
0.0137
Gnomad FIN
AF:
0.00268
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00111
Gnomad OTH
AF:
0.00216
GnomAD2 exomes
AF:
0.00865
AC:
1657
AN:
191546
AF XY:
0.00829
show subpopulations
Gnomad AFR exome
AF:
0.00607
Gnomad AMR exome
AF:
0.00546
Gnomad ASJ exome
AF:
0.00418
Gnomad EAS exome
AF:
0.00466
Gnomad FIN exome
AF:
0.0329
Gnomad NFE exome
AF:
0.00660
Gnomad OTH exome
AF:
0.00775
GnomAD4 exome
AF:
0.00192
AC:
2002
AN:
1043736
Hom.:
16
AF XY:
0.00205
AC XY:
1025
AN XY:
500924
show subpopulations
African (AFR)
AF:
0.00173
AC:
42
AN:
24264
American (AMR)
AF:
0.00175
AC:
33
AN:
18858
Ashkenazi Jewish (ASJ)
AF:
0.000550
AC:
7
AN:
12726
East Asian (EAS)
AF:
0.00177
AC:
32
AN:
18044
South Asian (SAS)
AF:
0.0113
AC:
364
AN:
32336
European-Finnish (FIN)
AF:
0.00984
AC:
182
AN:
18494
Middle Eastern (MID)
AF:
0.00607
AC:
19
AN:
3128
European-Non Finnish (NFE)
AF:
0.00136
AC:
1191
AN:
876156
Other (OTH)
AF:
0.00332
AC:
132
AN:
39730
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.406
Heterozygous variant carriers
0
66
132
198
264
330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00177
AC:
128
AN:
72166
Hom.:
1
Cov.:
0
AF XY:
0.00173
AC XY:
60
AN XY:
34618
show subpopulations
African (AFR)
AF:
0.00203
AC:
50
AN:
24590
American (AMR)
AF:
0.00174
AC:
12
AN:
6916
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1396
East Asian (EAS)
AF:
0.000968
AC:
2
AN:
2066
South Asian (SAS)
AF:
0.0136
AC:
18
AN:
1320
European-Finnish (FIN)
AF:
0.00268
AC:
10
AN:
3736
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
120
European-Non Finnish (NFE)
AF:
0.00111
AC:
34
AN:
30622
Other (OTH)
AF:
0.00216
AC:
2
AN:
928
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not specified (4)
-
-
2
Breast-ovarian cancer, familial, susceptibility to, 1 (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Familial cancer of breast (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147856441; hg19: chr17-41256100; COSMIC: COSV58784156; COSMIC: COSV58784156; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.